Designed by
patients for patients

Clarify Medical was founded by a psoriasis patient, Martyn Gross, who had excellent results with UVB therapy but found it very difficult to receive in-office treatment three times a week. His concept of a mobile, easy-to-use home UVB system, linked with the patient's physician, inspired years of research and development with hundreds of psoriasis and vitiligo patients and their physicians. Patients designed the integrated technology and service solution we offer today.

The Clarify Management Team

Our team of physicians, engineers, software experts, patient advisors and scientists are dedicated to creating new products and services that support patients and the clinicians who care for them.

Clarify. Life in a New Light.

James M. Sweeney

CEO and Director

Mr. Sweeney is a serial health care entrepreneur, responsible for founding and developing successful health care technology and service companies such as Caremark and CardioNet and for the successful LBO of McGaw, Inc., now part of B. Braun.

Charlene Kakimoto, MD

CMO

Charlene is a board certified dermatologist. Recently, Dr. Kakimoto served as Chief Medical Officer to an acne and anti-aging startup, Curology, which specializes in custom, prescription skincare. She served as Associate Professor of Dermatology for the Uniformed Services University in Bethesda MD, and with the Dermatology Residency Training Program, Navy Medical Center, in San Diego CA, where she also served as Director of the Outpatient Dermatology Clinic.

Don Canal

Don Canal has over 25 years of experience in the medical device industry serving in senior management positions in Design & Development, and Quality and Regulatory Affairs with startup companies such as CardioNet, Tandem Diabetes Care and most recently, Ivera Medical which was sold to 3M in March 2015. He has also served as VP GM for leading contract medical device design, research and development and manufacturing services.

Doug Eveland, PhD

Doug is a senior software technology executive with extensive experience in healthcare, having worked as a contributor at several San Diego health care startups including CardioNet, Bridge Medical and Radiation Oncology Computer Systems. He has also applied his skills with successful companies in the legal, banking, manufacturing and insurance fields. Doug earned a Ph.D in Experimental Psychology from the University of Texas at Arlington where he focused on cognitive and perceptual psychology, human factors engineering and multivariate statistics.

Wael Ahwal

Wael has 16 years of experience in the medical device and the diagnostic industry, holding senior positions in Design & Development, Software Validation and Verification, and Quality. Wael started his career at L3 Communication, moved to Gen-Probe, where he joined the Software Validation and Verification team as a lead. Most recently he served as Director of Quality Systems at Sotera Wireless.

Teddy Fulham

Prior to joining Clarify, Teddy was responsible for Strategy and Product Management at Sotera Wireless, and before that was a Market Manager for Pyxis Medication Management Technologies, owned by Becton Dickinson. Earlier, he held roles in corporate finance & accounting as well as business unit financial planning and analysis at CareFusion.

Andre Gamelin

Andre has over 20 years of experience in engineering innovative electro-mechanical and electro-optical products, primarily in the medical device field. Prior to Clarify Medical, Andre held leadership positions at CareFusion developing highly critical infusion pumps, at Masimo Corporation developing non-invasive blood gas sensors, and at Inovio Biomedical developing electroporation devices for cancer & DNA therapies.

Heidi Irwin

Heidi is a Board Certified Family Nurse Practitioner with a wide array of health care experience including specializing in both Dermatology and wound management.  Heidi’s most recent experience is in building and leading teams of virtual nurses and health care professionals across the nation.  Her clinical guidance and strategic planning have led to successful virtual patient support programs utilizing digital platforms for Pharmaceutical companies and within the chronic care management space. Her undergraduate training and education were completed at University of California, Los Angeles, and Graduate training at the University of California, San Diego School of Medicine.

Qun Xu, CFA

Before joining Clarify Medical, Qun worked in different functions at Sempra Energy with increasing responsibilities, including Business Development, M&A, Risk Management, and Natural Gas & Power trading. She graduated from UC San Diego with a Bachelors degree in Management Science and Masters degree in Economics. She also holds Chartered Financial Analyst (CFA) designation.

Matias Coo

Matias is a senior marketing executive and digital thought leader. His career in medtech began at Medtronic where he helped launch the world’s first sensor augmented insulin pump. He most recently worked in the CNS space for Avanir Pharmaceuticals and in April was recognized as one of the Top 40 Healthcare Transformers of 2017. His experience and expertise span both consumer and physician marketing and strategy.

The Clarify Board of Directors

David F. Hale

Mr. Hale serves as Chairman of the Board of Clarify Medical, Inc. He is Chairman and CEO of Hale Biopharma Ventures, LLC, a private company focused on the formation and development of biotechnology, specialty pharma, diagnostic and medical device companies. He was involved in the formation and development of SkinMedica, an aesthetic skincare company, and served as Executive Chairman and Chairman from 2001 through that company’s sale to Allergan for $315 million.

Mr. Hale served as Chairman of Santarus, Inc. prior to its sale to Salix Pharmaceuticals in 2014, Micromet prior to its sale to Amgen in 2012 for $1.2 billion, Somaxon Pharmaceuticals prior to its sale to Permix in 2013, and Crisi Medical Systems prior to its sale to Becton Dickinson & Co. in 2015.    

Mr. Hale is a serial entrepreneur who has been involved in the formation and/or development of many other life sciences companies. In addition to the companies above, these include Hybritech, Viagene, Gensia Sicor, CancerVax, Neurelis, MDRejuvena, Dermata, Adgica Health, Oncternal, Agility Clinical, Biocept, Neurana and Colorescience, Inc. He serves on the board of two public companies, Conatus and BIOCEPT.

James M. Sweeney

Mr. Sweeney serves as CEO of Clarify Medical. He was founder, Chairman and CEO of Home Health Care of America, later Caremark, which pioneered the home IV therapy industry and was sold to Baxter International for $528 million, and eventually to CVS for $24 billion. In 2014 CVS also purchased Coram Healthcare, an industry rollup Mr. Sweeney also founded, for $2.4 billion. Mr. Sweeney also led the successful LBO, turnaround and IPO of McGaw Inc, part of B. Braun Medical. Initial investors in McGaw received a sixfold increase in value in three and one half years, with a 77%  IRR.

Subsequently, he founded and served as Chairman and CEO of CardioNet, now BioTelemetry (NASDAQ: BEAT), a wireless healthcare company that introduced Mobile Cardiac Outpatient Telemetry, a life saving technology and service for detecting and diagnosing episodic arrhythmias. Its market capitalization is currently $1 billion.

Amit Pandya, MD

Dr. Pandya, a board certified dermatologist, is also a professor in the Department of Dermatology at the University of Texas Southwest Medical Center. He is a recipient of the Arnold P. Gold Foundation Humanism in Medicine Award from the American Academy of Dermatology and the University of Texas Regents’ Outstanding Teaching Award.

Dr. Pandya has also served as Clinical Director of the General Dermatology Clinic and Director of the Pharmaceutical Studies Unit at the University Medical Center and was elected by peers for inclusion in “Best Doctors in America” for many years. He has served as dermatological team leader and volunteer in many medical mission trips to Mexico and India and regularly serves as a volunteer dermatologist in clinics and disease screening projects in the United States.

Dr. Pandya is recognized as an international authority on pigmentary disorders, and is an author of over 117 peer reviewed publications and 45 book chapters and other publications on dermatologic disorders, as well as abstracts and articles. Dr. Pandya has also managed home phototherapy for hundreds of patients. Dr. Pandya’s expertise will be invaluable to Clarify in serving vitiligo patients and the physicians who treat them. An estimated 3 million individuals in the US alone have vitiligo and more than 60 million people worldwide are believed to suffer from the disease. Phototherapy delivered in combination with topical treatments is the gold standard of care for vitiligo patients; early intervention is key to success in re-pigmentation.

Rex Bright

Mr. Rex Bright is a specialty pharmaceuticals and biotech executive with extensive experience in dermatology. Mr. Bright spent 19 years with Johnson & Johnson where he headed the dermatology business until joining Allergan in 1983. At Allergan, he founded their skincare business and served as president until before becoming a startup and turnaround CEO. He has served as President & CEO of several successful pharmaceutical and biotechnology companies.

Mr. Bright co-founded SkinMedica in 2002 and served as President & CEO of SkinMedica until 2010. He continued to serve on the board until it was acquired by Allergan in 2012. He currently serves on the boards of Foamix Pharmaceuticals (NASD:FOMX), MDRejuvena and Clarify Medical. He is a member of the American Academy of Dermatology. He has completed executive programs at Harvard, Dartmouth, Stanford and Northwestern University and holds a B.A. degree in Business Administration from Drury University in Springfield, Missouri.

John T. Buhler

Mr. Buhler has been CEO/COO of three public and three private companies. He currently serves as Chief Executive Officer and President of Omniguide Holdings, Inc.

Mr. Buhler formerly served as CEO & President of RF Surgical Systems, President & COO of Natus Medical, CEO & President of SenoRx, and Ultrasonix Medical Corporation. He has over 30 years’ experience as a senior executive and business leader in medical technology companies such as GE Healthcare, and Diasonics VingMed Ultrasound, serving as Vice President and General Manager for both entities. At GE healthcare, Mr. Buhler headed up its global Performance Technologies division from 2001-2004. This position led commercial operations throughout Asia, delivering double digit revenue and margin growth annually.

Mr. Buhler has served as a Board Director for the following companies: GE-Wipro, Ultrasonix Medical Corporation, SenoRx Inc., Natus Medical, RF Surgical Systems, OmniGuide Holdings, Heart Force Medical, and Verrix.

Raymond Huggenberger

Mr. Huggenberger is a Director of Inogen, Inc. and served as its CEO from 2008-2017 and as its President from 2008-2016. Mr. Huggenberger led the company through a period of rapid revenue growth through direct-to-patient marketing, during which its share price increased.

He formerly served as President and COO and Group President of European Operations of Sunrise Medical Inc. He also previously served as President of Sunrise Medical Germany and as its Vice President of Marketing. Mr. Huggenberger also serves on the Board of Directors of Wellfount Corporation, Tactile Medical Systems and Sommetrics Inc. and is a member of the Technical Advisory Board of Arboretum Ventures LLP.

Mr. Huggenberger has over 20 years of deep experience in outpatient health care products and services, and in direct to patient and international sales and marketing.

Blog

White Patches on the Skin

WHY IT’S IMPORTANT TO DIAGNOSE AND TREAT EARLY If you or a loved one has developed white patches on the skin, it’s important to seek the advice of a dermatologist as soon as possible. Some conditions such as pityriasis alba, a common form of eczema, may be self-limited and curable. Other conditions, such as vitiligo,….

Why it’s time to Clarify… Home Phototherapy

Why it’s time to Clarify…home phototherapy is finally made easy, safe and effective! In recent years, I’ve been noticing articles written by dermatology key opinion leaders, including the current president of the American Academy of Dermatology, asking the question, “what happened to phototherapy?”  Despite light therapy’s long history of safety and efficacy, it has fallen out of….

News & Media

Contact Us.
We’re here to help.

Clarify Medical
401 W. A St. Suite 950
San Diego, CA 92101

Sales: +1 (877) 738-6041
Corporate: +1 (877) 520-5697
Fax: +1 (844) 562-6896

info@clarifymed.com

We are committed to providing innovative technology and support services for people with chronic skin conditions. We welcome your feedback and invite your questions.

Contact form